富豪汽車料次季錄減損費用達12億美元 股價急跌近半成
瑞典汽車製造商富豪汽車表示,第二季將面臨與兩款車型相關的一次性非現金減損費用高達114億瑞典克朗(約11.9億美元),該股股價在尾市交易中急跌約5%。
公司週一表示,由於先前的發佈延期和額外的開發成本,其即將推出的Volvo EX90電動SUV的生命週期盈利能力將下降。同時,由於進口關稅,公司目前無法在美國銷售其新款全電動Volvo ES90轎車並實現盈利。該公司又指,由於關稅的影響,ES90在歐洲的利潤率亦面臨壓力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.